DATASHEET
Host:
Rabbit
Target Protein:
ANGPTL3
Immunogen Range:
21-120/460
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
27329
Swiss Prot:
Q9Y5C1
Source:
KLH conjugated synthetic peptide derived from human ANG5/ANGPTL3
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Background:
Angiopoietin-like protein 3 (Angptl3) functions as a potent lipoprotein lipase inhibitor and is an important component of plasma triglyceride homeostasis. Angptl3 also plays a role in adipose formation and angiogenesis through its interaction with integrin ?v)beta(3). It is secreted by the liver and is functionally defined by the C-terminal fibrinogen (FBN)-like domain and an N-terminal coiled-coil domain. Angptl3 regulates circulating triglyceride levels during different nutritional states thereby mediating the feeding/fasting cycle. A deficiency of Angptl3 results in abnormally low lipid levels, and a repression of the protein may be protective against atherosclerosis. Angptl3 may also play an important role in hyperlipidemia in diabetes.
VALIDATION IMAGES
HepG2 lysates probed with ANGPTL3 Polyclonal Antibody, Unconjugated (bs-5918R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.
Lane 1: Human HL-60 cell Lysates; Lane 2: Human HepG2 cell Lysates; Lane 3: Human 293T cell Lysates; Lane 4: Human Raji cell Lysates; Lane 5: Human MOLT4 cell Lysates. Probed with ANGPTL3 polyclonal Antibody, unconjugated (bs-5918R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.